Viewing Study NCT01025232


Ignite Creation Date: 2025-12-24 @ 9:40 PM
Ignite Modification Date: 2025-12-31 @ 1:18 AM
Study NCT ID: NCT01025232
Status: TERMINATED
Last Update Posted: 2017-01-02
First Post: 2009-12-02
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of Intravitreal Injections of 2.0mg Ranibizumab in Subjects With Chronic Fluid On OCT Post Multiple Injections With Ranibizumab (Super-dose Anti-VEgf SAVE Trial)
Sponsor: David M. Brown, M.D.
Organization: